PT100329A - Composicoes a base de di-hidro-4-(3,5-di-terc-butil-4-hidroxi-benzilideno)-metil-2h-1,2-oxazin-3(4h)-ona sob forma micronizada - Google Patents

Composicoes a base de di-hidro-4-(3,5-di-terc-butil-4-hidroxi-benzilideno)-metil-2h-1,2-oxazin-3(4h)-ona sob forma micronizada

Info

Publication number: PT100329A
Authority: PT; Portugal
Prior art keywords: micronized; terc; oxazin; benzylidene; hydro
Prior art date: 1991-04-05

Application number

PT100329A

Other languages

English (en)

Other versions

PT100329B (pt

Inventor

Sung J Lee

Original Assignee

Biofor Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-04-05

Filing date

1992-04-01

Publication date

1993-07-30

1992-04-01 Application filed by Biofor Ltd filed Critical Biofor Ltd

1993-07-30 Publication of PT100329A publication Critical patent/PT100329A/pt

1999-06-30 Publication of PT100329B publication Critical patent/PT100329B/pt

Links

239000000203 mixture Substances 0.000 title abstract 2
239000004480 active ingredient Substances 0.000 abstract 1
230000003110 anti-inflammatory effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Cosmetics (AREA)
Lubricants (AREA)
Compositions Of Macromolecular Compounds (AREA)

PT100329A 1991-04-05 1992-04-01 Composicoes a base de di-hidro-4-(3,5-di-terc-butil-4-hidroxi-benzilideno)-metil-2h-1,2-oxazin-3(4h)-ona sob forma micronizada PT100329B (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/680,997 US5271944A (en)	1991-04-05	1991-04-05	Pharmacologically enhanced formulations

Publications (2)

Publication Number	Publication Date
PT100329A true PT100329A (pt)	1993-07-30
PT100329B PT100329B (pt)	1999-06-30

Family

ID=24733350

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT100329A PT100329B (pt)	1991-04-05	1992-04-01	Composicoes a base de di-hidro-4-(3,5-di-terc-butil-4-hidroxi-benzilideno)-metil-2h-1,2-oxazin-3(4h)-ona sob forma micronizada

Country Status (16)

Country	Link
US (1)	US5271944A (pt)
EP (1)	EP0599914B1 (pt)
AT (1)	ATE155687T1 (pt)
AU (1)	AU1876792A (pt)
CA (1)	CA2052901C (pt)
CH (1)	CH683824A5 (pt)
DE (1)	DE69221150T2 (pt)
DK (1)	DK0599914T3 (pt)
ES (1)	ES2108130T3 (pt)
FR (1)	FR2674754B1 (pt)
IE (1)	IE74211B1 (pt)
IT (1)	ITTO920303A1 (pt)
NZ (1)	NZ242233A (pt)
PT (1)	PT100329B (pt)
WO (1)	WO1992017163A1 (pt)
ZA (1)	ZA922482B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2684298B1 (fr) *	1991-12-03	1994-03-11	Rhone Poulenc Rorer Sa	Nouvelles compositions pharmaceutiques solides a base de derives de lapiperidine substitues en 1,4.
DE69624559T2 (de) *	1995-02-28	2003-07-10	Aventis Pharmaceuticals Inc., Bridgewater	Arzneizubereitungen für piperidinalkanolderivate
EP0998272B1 (en) *	1997-08-26	2003-05-02	Aventis Pharmaceuticals Inc.	Pharmaceutical composition for combination of piperidinoalkanol-decongestant
IL152411A0 (en) *	2000-04-24	2003-05-29	Teva Pharma	Zolpidem hemitartrate
EP1475093B1 (en)	2000-04-24	2006-09-06	Teva Pharmaceutical Industries Ltd.	Micronized Zolpidem hemitartrate
JP2004537506A (ja)	2001-03-01	2004-12-16	ホリス − イーデンファーマスーティカルズ、インコーポレイテッド	血液細胞欠乏症を治療するためのある種のステロイドの使用
US20060280761A1 (en) *	2002-03-11	2006-12-14	Health Plus International, Inc.	Nanofluidized B-12 composition and process for treating pernicious anemia
US6861066B2 (en) *	2002-03-11	2005-03-01	Health Plus International Inc.	Method for the delivery of a biologically active agent
BE1015641A4 (fr) *	2003-05-26	2005-07-05	Mariani Jean Paul	Micronisation 70.
ES2284068T3 (es) *	2003-10-16	2007-11-01	Teva Pharmaceutical Industries Limited	Preparacion de candesartan cilexetilo.
CA2552003A1 (en) *	2004-01-05	2005-07-28	Teva Pharmaceutical Industries Ltd.	Methods for the production of sildenafil base and citrate salt
CA2555294A1 (en) *	2004-02-11	2005-08-25	Marina Yu Etinger	Candesartan cilexetil polymorphs
AU2005330504B2 (en)	2004-09-29	2010-10-28	Harbor Biosciences, Inc.	Steroid analogs and characterization and treatment methods
CA2728889C (en)	2008-04-03	2016-06-14	Harbor Biosciences, Inc.	Solid state forms of a pharmaceutical
TW201613888A (en)	2014-09-26	2016-04-16	Helsinn Healthcare Sa	Crystalline forms of an NK-1 antagonist

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3033919A1 (de) *	1980-09-09	1982-04-22	Bayer Ag, 5090 Leverkusen	Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung
DE3204126A1 (de) *	1982-02-06	1983-08-11	Bayer Ag, 5090 Leverkusen	Pyrazoloxazine, -thiazine, -chinoline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
IT1187751B (it) *	1985-10-15	1987-12-23	Eurand Spa	Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute
US4912093A (en) *	1986-10-01	1990-03-27	Marion Laboratories, Inc.	Use of synthetic sulfated saccharides to enhance wound healing
DE3723327A1 (de) *	1987-07-15	1989-02-02	Hoechst Ag	Substituierte thienoimidazol-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung als magensaeuresekretionshemmer, magenschutzmittel sowie als medikament gegen intestinale entzuendungen
US4892870A (en) *	1988-08-01	1990-01-09	Biofor, Ltd.	Oxaza heterocycles and pharmaceutical compositions containing same

1991
- 1991-04-05 US US07/680,997 patent/US5271944A/en not_active Expired - Fee Related
- 1991-10-07 CA CA002052901A patent/CA2052901C/en not_active Expired - Fee Related
1992
- 1992-03-31 DK DK92917294.8T patent/DK0599914T3/da active
- 1992-03-31 AT AT92917294T patent/ATE155687T1/de not_active IP Right Cessation
- 1992-03-31 WO PCT/US1992/002436 patent/WO1992017163A1/en not_active Ceased
- 1992-03-31 DE DE69221150T patent/DE69221150T2/de not_active Expired - Fee Related
- 1992-03-31 AU AU18767/92A patent/AU1876792A/en not_active Abandoned
- 1992-03-31 ES ES92917294T patent/ES2108130T3/es not_active Expired - Lifetime
- 1992-03-31 EP EP92917294A patent/EP0599914B1/en not_active Expired - Lifetime
- 1992-04-01 PT PT100329A patent/PT100329B/pt not_active IP Right Cessation
- 1992-04-02 IT IT92TO000303A patent/ITTO920303A1/it not_active Application Discontinuation
- 1992-04-02 IE IE921040A patent/IE74211B1/en not_active IP Right Cessation
- 1992-04-03 ZA ZA922482A patent/ZA922482B/xx unknown
- 1992-04-03 NZ NZ242233A patent/NZ242233A/xx unknown
- 1992-04-03 FR FR9204122A patent/FR2674754B1/fr not_active Expired - Fee Related
- 1992-04-06 CH CH1108/92A patent/CH683824A5/de not_active IP Right Cessation

Also Published As

Publication number	Publication date
CA2052901A1 (en)	1992-10-06
IE74211B1 (en)	1997-07-16
EP0599914B1 (en)	1997-07-23
FR2674754A1 (fr)	1992-10-09
NZ242233A (en)	1993-07-27
FR2674754B1 (fr)	1994-01-14
US5271944A (en)	1993-12-21
ZA922482B (en)	1992-12-30
EP0599914A1 (en)	1994-06-08
ITTO920303A0 (it)	1992-04-02
CA2052901C (en)	1997-12-23
DK0599914T3 (da)	1998-03-02
AU1876792A (en)	1992-11-02
DE69221150T2 (de)	1998-02-26
PT100329B (pt)	1999-06-30
IE921040A1 (en)	1992-10-07
CH683824A5 (de)	1994-05-31
EP0599914A4 (en)	1994-08-24
WO1992017163A1 (en)	1992-10-15
ITTO920303A1 (it)	1993-10-02
ES2108130T3 (es)	1997-12-16
DE69221150D1 (de)	1997-09-04
ATE155687T1 (de)	1997-08-15

Similar Documents

Publication	Publication Date	Title
IT8619004A0 (it)	1986-01-03	Sali idrosulubili di composti adattivita' antiinfiammatoria ed analgesica, loro preparazione ed utilizzo in composizioni farmaceutiche.
NO921947D0 (no)	1992-05-15	Antivirale blandinger
NZ216657A (en)	1989-10-27	N-buten-3-yl-azaheterocyclic carboxylic acid compounds and pharmaceutical compositions
RU93004970A (ru)	1997-04-10	Производные циклоалкилзамещенного глутарамида, их применение, фармацевтическая композиция
NO943761L (no)	1995-04-10	Oralt administrerbare opioide formuleringer med forlenget effektvarighet
ATE155687T1 (de)	1997-08-15	Pharmakologisch verbesserte formulierungen
ES2086371T3 (es)	1996-07-01	1,3-oxatiolanos sustituidos con propiedades antiviricas.
IL80149A (en)	1990-11-29	Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
IT1226549B (it)	1991-01-24	Composizioni farmaceutiche ad attivita' analgesica ed antiinfiammatoria per uso orale, dotate di ottima palatabilita' ed esenti da effetti irritanti sulle mucose.
DK0598770T3 (da)	1997-12-15	Pyrazinderivater samt fremstilling og anvendelse deraf
EP0537492A3 (en)	1993-06-23	Stable salts of 5,10-methylenetetrahydrofolic acid
DE3774415D1 (de)	1991-12-12	Pharmazeutische zusammensetzung fuer die prophylaxe und die therapie des magengeschwuers.
ATE67932T1 (de)	1991-10-15	Pharmazeutische zusammensetzungen fuer suppositorien.
DK0505180T3 (da)	1997-03-24	Farmaceutisk præparat med højt indhold af ibuprofenlysinat
NO903058D0 (no)	1990-07-09	Farmasoeytisk preparat med forbedret absorberbarhet.
SE8902607D0 (sv)	1989-07-27	Oxaza heterocycles and pharmaceutical compositions containing same
IE830264L (en)	1983-09-01	Anti-inflammatory composition based on essential fatty-acids¹and biotin
IT1243358B (it)	1994-06-10	Composizioni farmaceutiche per la somministrazione orale di irudina
ATE187430T1 (de)	1999-12-15	In position 10 substituierte 1,8-dihydroxy-9(10h)-anthracenon pharmazeutika
ITMI911888A1 (it)	1993-01-09	Composizioni farmaceutiche utilizzabili in gastroenterologia
IT1265342B1 (it)	1996-11-22	Composizioni farmaceutiche a base di derivati della glicina
ITFI920089A0 (it)	1992-04-15	Composti triciclici antagonisti delle tachichinine, loro preparazione e loro uso in composizioni farmaceutiche.
ES2032838T3 (es)	1993-03-01	Un procedimiento para preparar derivados tetrahidropirido (1,2-a)indol.
IT8219804A0 (it)	1982-02-23	Formulazioni farmaceutiche adattivita' antiinfiammatoria, analgesica, antipiretica e gastroprotettiva.
KR880012518A (ko)	1988-11-28	나프탈-아세트산 유도체를 함유하는 진통 및 소염제약 조성물

Legal Events

Date

Code

Title

Description

1993-07-30

BB1A

Laying open of patent application

Effective date: 19930303

1999-06-30

FG3A

Patent granted, date of granting

Effective date: 19990329

2002-01-30

MM3A

Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20010930